Trident Lifeline Limited

BSE: TLL543616ISIN INE0MKA01014

Healthcare
Pharmaceuticals

Share price

₹418.00+1.00 (+0.24%)

as of 4 Nov 2026

Prices adjusted for splits and bonuses; cash dividends excluded. Volume shows actual shares traded.

52W high: ₹442.00
52W low: ₹229.95
Off 52W high: -5.43%
1M return: +7.43%
3M return: +64.05%
6M return: +67.40%
1Y return: +39.33%
20D avg volume: 26,190
50 DMA: ₹356.22
200 DMA: ₹286.10

Key ratios Consolidated

Market cap: ₹499.80 Cr
Current price: ₹418.00
52W high / low: ₹442.00 / ₹229.95
Face value: ₹10.00
P/E: —
P/B: —
EPS (TTM): —
Book value / share: —
ROE: —
ROCE: 21.00%
Operating margin: —
Net margin: —
Debt / equity: —
Net debt: —
Interest cover: 7.60
Dividend yield: 0.12%
Dividend / share (TTM): ₹0.50
Payout: —
Cash conversion cycle: 202.8 days

Financials

Metric	Q2 FY27	Q1 FY27	Q4 FY26	Q3 FY26	Q2 FY26	Q1 FY26	Q4 FY25	Q1 FY25	Q4 FY24	Q1 FY24	Q3 FY23
Income statement
	—	33.72	—	25.71	—	23.61	—	13.15	—	8.64	9.41
	—	0.57	—	4.63	—	1.35	—	1.15	—	0.33	0.40
	—	34.29	—	30.34	—	24.96	—	14.30	—	8.97	9.80
	—	27.69	—	24.32	—	21.02	—	11.69	—	7.11	7.68
	—	11.99	—	17.47	—	11.78	—	6.63	—	4.08	4.74
	—	2.28	—	0.52	—	2.05	—	0.83	—	1.20	2.69
	—	1.69	—	2.53	—	2.68	—	1.10	—	0.48	0.37
	—	0.86	—	1.24	—	1.13	—	0.49	—	0.10	0.13
	—	1.62	—	2.46	—	1.46	—	0.54	—	0.13	0.13
	—	3.23	—	3.03	—	4.81	—	1.85	—	0.99	0.84
	—	6.61	—	6.02	—	3.93	—	2.61	—	1.86	2.12
	—	0.00	—	0.00	—	0.00	—	0.00	—	0.00	0.00
	—	6.61	—	6.02	—	3.93	—	2.61	—	1.86	2.12
	—	1.54	—	1.37	—	1.15	—	1.01	—	0.46	0.10
	—	5.07	—	4.65	—	2.78	—	1.60	—	1.40	2.02
	—	4.27	—	3.72	—	2.66	—	—	—	—	—
Key metrics
	—	9.09	—	9.72	—	6.52	—	3.64	—	2.09	2.38
	—	27.00%	—	37.80%	—	27.60%	—	27.70%	—	24.20%	25.30%
	—	15.00%	—	18.10%	—	11.80%	—	12.20%	—	16.20%	21.50%
	—	42.80%	—	—	—	79.50%	—	52.20%	—	—	—
	—	82.40%	—	—	—	73.70%	—	14.30%	—	—	—

Metric	FY26	FY25	FY24	FY23
Income statement
	129.02	86.97	44.63	31.69
	9.27	8.23	2.08	1.16
	138.29	95.20	46.71	32.85
	111.10	81.58	38.01	26.27
	59.94	43.05	21.12	12.19
	9.17	1.80	9.46	10.93
	10.78	12.09	2.40	1.61
	4.12	3.99	0.60	0.47
	—	5.49	0.97	0.36
	13.67	14.46	—	3.61
	27.19	13.62	8.70	6.58
	0.00	0.00	0.00	0.00
	27.19	13.62	8.70	6.58
	7.87	3.12	2.76	0.56
	19.32	10.49	5.94	6.01
	16.32	10.22	—	—
Key metrics
	31.31	23.10	10.27	7.41
	24.30%	26.60%	23.00%	23.40%
	15.00%	12.10%	13.30%	19.00%
	21.00%	17.20%	—	—
	48.40%	94.90%	40.80%	—
	84.20%	76.60%	-1.20%	—
	-31.78	-21.34	—	—
	0.24	-0.98	—	—
	202.8	172.6	—	—
Balance sheet
	236.83	156.01	—	—
	139.51	90.37	—	—
	4.22	2.46	—	—
	73.65	27.68	—	—
	36.44	28.24	—	—
	8.60	11.68	—	—
	42.58	34.96	—	—
	38.43	14.79	—	—
	87.89	53.55	—	—
Cash flow
	4.69	-10.24	—	—
	-36.61	-13.82	—	—
	33.68	19.76	—	—
	36.47	11.10	—	—

Metric	Q2 FY27	Q1 FY27	Q4 FY26	Q3 FY26	Q2 FY26	Q1 FY26	Q4 FY25	Q1 FY25	Q4 FY24	Q1 FY24	Q3 FY23
Income statement
	—	26.84	—	23.67	—	18.82	—	14.74	—	8.64	9.41
	—	0.53	—	0.89	—	0.54	—	0.47	—	0.33	0.40
	—	27.37	—	24.56	—	19.36	—	15.21	—	8.97	9.80
	—	20.81	—	18.64	—	14.73	—	11.19	—	7.11	7.68
	—	13.80	—	15.52	—	11.45	—	6.61	—	4.08	4.74
	—	2.20	—	0.53	—	0.66	—	1.07	—	1.20	2.67
	—	0.97	—	0.79	—	0.87	—	0.52	—	0.48	0.37
	—	0.49	—	0.54	—	0.33	—	0.20	—	0.10	0.13
	—	0.70	—	0.71	—	0.51	—	0.33	—	0.13	0.13
	—	2.82	—	2.49	—	2.77	—	1.96	—	0.99	0.84
	—	6.56	—	5.92	—	4.63	—	4.02	—	1.86	2.12
	—	6.56	—	5.92	—	4.63	—	4.02	—	1.86	2.12
	—	1.54	—	1.91	—	1.15	—	1.01	—	0.46	0.10
	—	5.02	—	4.01	—	3.48	—	3.01	—	1.40	2.02
	—	4.26	—	3.47	—	3.02	—	—	—	—	—
Key metrics
	—	7.75	—	7.17	—	5.47	—	4.55	—	2.09	2.38
	—	28.90%	—	30.30%	—	29.10%	—	30.90%	—	24.20%	25.30%
	—	18.70%	—	16.90%	—	18.50%	—	20.40%	—	16.20%	21.50%
	—	42.60%	—	—	—	27.70%	—	70.60%	—	—	—
	—	44.30%	—	—	—	15.60%	—	115.00%	—	—	—

Metric	FY26	FY25	FY24	FY23
Income statement
	101.90	67.80	44.65	31.69
	4.17	3.14	2.20	1.15
	106.07	70.94	46.85	32.85
	81.09	53.03	37.06	26.27
	55.38	32.86	20.71	12.19
	8.85	1.88	9.52	10.93
	3.81	3.07	2.02	1.61
	1.66	1.23	0.46	0.47
	1.86	1.53	0.77	0.36
	11.48	11.00	4.24	3.61
	24.98	17.91	9.80	6.57
	24.98	17.91	9.80	6.57
	6.89	4.85	2.76	0.56
	18.09	13.05	7.04	6.01
	15.50	11.35	—	—
Key metrics
	28.50	20.67	11.03	7.40
	28.00%	30.50%	24.70%	23.40%
	17.80%	19.20%	15.80%	19.00%
	24.90%	26.30%	—	—
	50.30%	51.80%	40.90%	—
	38.60%	85.40%	17.10%	—
	-7.19	-8.70	—	—
	0.44	-0.27	—	—
	166.7	147.0	—	—
Balance sheet
	159.19	97.79	—	—
	110.06	69.14	—	—
	4.07	2.11	—	—
	49.34	20.40	—	—
	23.22	16.57	—	—
	2.47	4.78	—	—
	18.27	8.00	—	—
	26.03	9.65	—	—
	52.38	25.14	—	—
Cash flow
	7.93	-3.49	—	—
	-20.07	-7.88	—	—
	14.10	7.47	—	—
	15.12	5.21	—	—

Compounded growth

Standalone

Sales CAGR 3Y: +47.60%
Sales CAGR 5Y: —
Profit CAGR 3Y: +44.38%
Profit CAGR 5Y: —
Sales YoY (TTM): —
Profit YoY (TTM): —

Consolidated

Sales CAGR 3Y: +59.68%
Sales CAGR 5Y: —
Profit CAGR 3Y: +47.59%
Profit CAGR 5Y: —
Sales YoY (TTM): —
Profit YoY (TTM): —

Compounded from reported annual figures. We publish no share-price CAGR: our prices are as-traded, so one would be wrong across every split and bonus issue.

Shareholding as of 21 Oct 2026

Promoter holding: 62.53%

Quarter	21 Oct 2026	September 2026	June 2026
Promoter %	62.53%	62.53%	62.46%

Holder	Type	Holding	Previous	Change
Desai Hardik Jigishkumar	Promoter	23.02%	23.02%	0.00%
HARDIK JIGISHKUMAR DESAI, MANIYA HARDIK DESAI, ANJANABEN JIGISHKUMAR DESAI ON BEHALF OF HARDIK DESAI FAMILY TRUST	Promoter Group	7.16%	7.16%	0.00%
Anjanaben Jigishkumar Desai	Promoter Group	7.00%	7.00%	0.00%
Tarang Nathabhai Gajera	Promoter	5.60%	5.60%	0.00%
Rupaben Chetanbhai Jariwala	Promoter	5.17%	5.17%	0.00%
Mayurkumar Mansukhbhai Gajera	Promoter	3.96%	3.96%	0.00%
Mohak Gajera	Promoter	3.96%	3.96%	0.00%
Rinkal Mayurbhai Gajera	Promoter	3.33%	3.33%	0.00%
Goenka Business And Finance Limited	Public	3.01%	3.01%	0.00%
Trident Texofab Limited	Promoter Group	0.91%	0.91%	0.00%
Amit Bhupendra Halvawala	Promoter Group	0.85%	0.85%	0.00%
Maniya Hardik Desai	Promoter Group	0.83%	0.83%	0.00%
Niyati Roshan Thakkar	Promoter Group	0.54%	0.54%	0.00%
Vishal Bhupendrabhai Halvawala	Promoter Group	0.20%	0.20%	0.00%

Public shareholders are disclosed individually only above 1%.

Peer comparison

Company	Mkt cap (₹ Cr)	Price (₹)	P/E	ROCE	Sales YoY	Profit YoY	1Y return
Sun Pharmaceutical Industries Ltd.	4,26,112	1,776.00	38.78	17.90%	+12.13% TTM	+4.79% TTM	+4.92%
Divi's Laboratories Ltd.	2,66,424	10,036.00	91.09	19.00%	+16.35% TTM	+26.84% TTM	+47.61%
Torrent Pharmaceuticals Ltd.	1,79,908	4,730.00	85.71	9.10%	+42.06% TTM	-1.92% TTM	+32.24%
Laurus Labs Limited	1,24,601	2,306.10	93.53	19.70%	+23.03% TTM	+95.38% TTM	+134.59%
Zydus Lifesciences Limited	1,18,703	1,190.00	25.85	19.20%	+21.11% TTM	-2.51% TTM	+22.32%
Dr. Reddy's Laboratories Ltd.	1,14,513	1,372.00	41.50	13.90%	-3.53% TTM	-51.90% TTM	+14.26%
Cipla Ltd.	1,13,110	1,400.10	39.63	14.90%	-0.74% TTM	-47.48% TTM	-6.88%
Mankind Pharma Limited	1,04,631	2,533.15	46.22	13.70%	+13.27% TTM	+27.60% TTM	+6.91%
Aurobindo Pharma Ltd.	97,878	1,701.10	26.38	13.60%	+9.09% TTM	+9.48% TTM	+47.79%
Lupin Ltd	92,145	2,015.00	17.65	28.40%	+24.22% TTM	+20.10% TTM	+0.84%
Glenmark Pharmaceuticals ltd	70,608	2,501.85	39.27	16.20%	+32.94% TTM	+138.48% TTM	+35.48%
Alkem Laboratories Limited	62,054	5,190.00	28.15	18.80%	+13.36% TTM	-5.52% TTM	-8.38%
Abbott India Ltd. S	57,685	27,146.85	35.73	41.90%	+6.29% TTM	+11.18% TTM	-7.56%
Biocon Ltd.	56,061	344.00	134.63	2.90%	+5.70% TTM	-55.37% TTM	-9.53%
Gland Pharma Limited	52,105	3,157.70	46.16	13.70%	+17.57% TTM	+46.55% TTM	+65.09%
Ipca Laboratories Ltd.	50,051	1,973.15	36.40	16.40%	+10.59% TTM	+67.91% TTM	+52.33%
GlaxoSmithkline Pharmaceuticals Ltd.	42,904	2,532.60	37.42	55.40%	+12.12% TTM	+20.03% TTM	-4.84%
Ajanta Pharma Ltd.	41,406	3,313.55	32.79	29.40%	+25.01% TTM	+29.70% TTM	+26.89%
Emcure Pharmaceuticals Limited	41,254	2,174.55	37.75	25.10%	+21.12% TTM	+33.34% TTM	+64.07%
J.B. Chemicals & Pharmaceuticals Lt	38,731	2,412.25	47.77	21.90%	+5.87% TTM	+7.56% TTM	+45.79%
Sai Life Sciences Limited	32,855	1,546.30	90.80	18.10%	—	—	+67.49%
PIRAMAL PHARMA LIMITED	31,659	237.80	-151.21	0.80%	+9.43% TTM	-781.93% TTM	+18.60%
ACUTAAS CHEMICALS LIMITED	30,928	3,777.65	70.51	27.70%	+45.18% TTM	+95.78% TTM	+106.30%
Wockhardt Ltd	30,869	1,899.80	76.22	6.40%	+25.70% TTM	+894.12% TTM	+39.18%
RUBICON RESEARCH LIMITED	28,416	1,716.55	98.59	24.30%	—	—	+164.06%
Trident Lifeline Limited	500	418.00	—	21.00%	—	—	+39.33%

Filings & corporate actions

Recent announcements

With reference to the Financial Result submitted on October 26, 2026 and Revised Financial Results submitted by the Company on October 27, 2026, pursuant to Regulation 30 and Regulation ....4 Nov 2026 · Company Update / General
In terms of regulation 30 of the SEBI (Listing Obligations and Disclosure Requirement) Regulations, 2015, please find enclosed herewith a copy of Press Release for the Unaudited Financial ....29 Oct 2026 · Company Update / Press Release / Media Release
In accordance with Regulation 47 and other applicable provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, we hereby enclose copies of newspaper advertisement ....29 Oct 2026 · Company Update / Newspaper Publication
Pursuant to Regulation 44(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed details of voting results inclusive of remote e-voting ....29 Oct 2026 · AGM/EGM / EGM
Revised Un-Audited Financial Statement for the Half Year ended 30.09.202627 Oct 2026 · Company Update / General
We are resubmitting the Financial Results due to an inadvertent error in the previously filed results dated 26.10.2026. We regret the inconvenience caused and request you to consider the revised ....27 Oct 2026 · Result / Financial Results
We are resubmitting the Financial Results due to an inadvertent error in the previously filed results dated 26.10.2026. We regret the inconvenience caused and request you to consider the revised ....27 Oct 2026 · Company Update / General
Further to our letter dated 05th October, 2026 and pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('SEBI Listing Regulations'), ....27 Oct 2026 · AGM/EGM / EGM
Declared a First interim dividend for Financial Year 2026-2726 Oct 2026 · Corp Action / Dividend Updates
The 'Record Date' for determining entitlement of members of the Company for the aforesaid Interim Dividend will be Friday, October 30, 202626 Oct 2026 · Corp. Action / Record Date
Declared a First interim dividend for Financial Year 2026-2726 Oct 2026 · Corp. Action / Dividend
The Board of Directors inter-alia has approved and taken on record Un-Audited Standalone and Consolidated Financial Results for the half year ended 30th September, 2026. (The copy of Un-Audited ....26 Oct 2026 · Result / Financial Results
Outcome of Board Meeting held on 26.10.202626 Oct 2026 · Board Meeting / Outcome of Board Meeting
Please find enlsoed herewith copy of 24A.23 Oct 2026 · Company Update / Reg.24(A)-Annual Secretarial Compliance
Trident Lifeline Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/10/2026 ,inter alia, to consider and approve 1. Unaudited Financial Results ....21 Oct 2026 · Board Meeting / Board Meeting
Allotment of 24000 Equity Shares pursuant to conversion of warrants.17 Oct 2026 · Company Update / Allotment of Equity Shares
Allotment of 24000 Equity Shares Pursuant to conversion of Warrants.17 Oct 2026 · Others / Outcome without intimation
Please find attached herewith copies of the newspaper advertisements published in Financial Express (English) and Financial Express (Gujarati) regarding the corrigendum to the Notice of ....17 Oct 2026 · Company Update / Newspaper Publication
Trident Lifeline Limited has issued corrigendum to the Notice of EOGM16 Oct 2026 · AGM/EGM / EGM
Outcome of Board Meeting held on 16.10.202616 Oct 2026 · Others / Outcome without intimation
We wish to inform to the Exchange that TRIDENT MEDIQUIP LIMITED (TML) (CIN: U33309GJ2019PLC110421), a subsidiary company has made Private Placement of equity shares to other shareholders. ....15 Oct 2026 · Company Update / Acquisition
Please find enclosed Press Release titled 'CPHI Milan 2026: Opening doors to regulated markets and new global business opportunities' issued on October 09, 2026.9 Oct 2026 · Company Update / Press Release / Media Release
Please find enclosed herewith the Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 as received from MUFG Intime India Private Limited (Formally ....8 Oct 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Please find attached herewith copies of newspaper advertisements published in the Financial Express (English) and Financial Express (Gujarati), regarding notice of Extra Ordinary General ....6 Oct 2026 · Company Update / Newspaper Publication
This is in continuation of the Outcome of the Board Meeting submitted by the Company to the Exchange on October 05, 2026 regarding the Board Meeting held on October 5, 2026 pursuant to ....6 Oct 2026 · Company Update / General
We would like to inform you that the Extra-Ordinary General Meeting is scheduled to be held on Tuesday, October 27, 2026, at 04.00 p.m.(IST) through Video Conferencing ("VC") or Other Audio ....5 Oct 2026 · AGM/EGM / EGM
The Board of Director has approved the alteration of Article of Association, subject to the approval of Members5 Oct 2026 · Company Update / Amendments to Memorandum & Articles of Association
Trident Lifeline Limited has announced the issue of Equity shares and Warrants on preferential basis.5 Oct 2026 · Company Update / Issue of Securities
Outcome of Board Meeting held on 05.10.20265 Oct 2026 · Board Meeting / Outcome of Board Meeting
Pursuant to Regulation 30(6) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements), Regulations, 2015, we would like to inform you that the Company ....3 Oct 2026 · Company Update / Analyst / Investor Meet
Pursuant to Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby submit the outcome of the Analysts/Investors ....1 Oct 2026 · Company Update / Analyst / Investor Meet
With reference to our letter dated September 29, 2026 and Pursuant to SEBI (Prohibition of Insider Trading) Regulation, 2015, we wish to inform you that the Trading Window for dealing in ....30 Sep 2026 · Insider Trading / SAST / Closure of Trading Window
We wish to inform to the Exchange that Trident Lifeline Limited has made further Investment by acquiring an additional equity stake of 1.00% of TRIDENT MEDIQUIP LIMITED (TML) (CIN: U33309GJ2019PLC110421), ....30 Sep 2026 · Company Update / Acquisition
Trident Lifeline Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/10/2026 ,inter alia, to consider and approve 1. the proposal to raise funds, ....29 Sep 2026 · Board Meeting / Board Meeting
Pursuant to Regulation 44(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed details of voting results inclusive of remote e-voting ....28 Sep 2026 · AGM/EGM / AGM
We wish to inform you that the Company has scheduled a one-on-one plant visit meeting at its units situated in Surat, Gujarat, with Stylus Holdings on 28th September (Monday).28 Sep 2026 · Company Update / Analyst / Investor Meet
Further to our letter dated 04th September, 2026 and pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('SEBI Listing Regulations'), ....26 Sep 2026 · AGM/EGM / AGM
We wish to inform you that company has scheduled a plant visit at its units situated in Vapi and Surat (Gujarat) for Group of Investors/Analysts on Thursday, October 1, 2026.26 Sep 2026 · Company Update / Analyst / Investor Meet
This is with reference to your email dated 23rd September, 2026 and Letter No. L/SURV/ONL/PV/SJ/ 2026-2027 / 4283 received from BSE seeking clarification regarding the significant movement ....24 Sep 2026 · Company Update / General
The Exchange has sought clarification from Trident Lifeline Ltd on September 23, 2026 with reference to significant movement in price, in order to ensure that investors have latest relevant ....23 Sep 2026 · Company Update / Clarification

Corporate actions

Purpose	Ex date	Record date	Payment date
Interim Dividend - Rs. - 0.5000	30 Oct 2026	30 Oct 2026	—

Board meetings

26 Oct 2026 Board Meeting - Financial Results
29 Jul 2026 Board Meeting - Financial Results